HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Yoichi Naito Selected Research
Yoichi Naito Research Topics
Disease
54
Neoplasms (Cancer)
05/2024 - 06/2007
33
Breast Neoplasms (Breast Cancer)
05/2024 - 08/2010
8
Disease Progression
05/2024 - 06/2007
5
Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
05/2024 - 06/2008
5
Neoplasm Metastasis (Metastasis)
12/2023 - 04/2013
4
Colorectal Neoplasms (Colorectal Cancer)
12/2021 - 04/2013
4
Carcinoma (Carcinomatosis)
10/2021 - 07/2013
4
Triple Negative Breast Neoplasms
03/2021 - 01/2019
3
Peripheral Nervous System Diseases (PNS Diseases)
11/2023 - 02/2021
3
Leiomyosarcoma
12/2021 - 06/2017
3
Exanthema (Rash)
12/2021 - 10/2016
3
Sarcoma (Soft Tissue Sarcoma)
01/2020 - 01/2017
3
Nausea
01/2020 - 04/2019
3
Vomiting
01/2020 - 04/2019
3
Neutropenia
10/2016 - 02/2015
2
Interstitial Lung Diseases (Interstitial Lung Disease)
01/2023 - 08/2008
2
Infections
01/2023 - 01/2013
2
Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor)
01/2023 - 10/2014
2
Ovarian Neoplasms (Ovarian Cancer)
01/2020 - 12/2010
2
Adenocarcinoma
05/2019 - 04/2013
2
Diarrhea
04/2019 - 10/2016
2
Febrile Neutropenia
01/2019 - 01/2013
2
Renal Cell Carcinoma (Grawitz Tumor)
11/2018 - 07/2013
2
Brain Neoplasms (Brain Tumor)
01/2015 - 08/2014
2
Small Cell Lung Carcinoma (Small Cell Lung Cancer)
01/2011 - 06/2007
2
Lymphatic Metastasis
08/2010 - 06/2007
1
Melanoma (Melanoma, Malignant)
12/2023
1
Gastritis
12/2023
1
Pain (Aches)
11/2023
1
Hyperphosphatemia
02/2023
1
Stomach Neoplasms (Stomach Cancer)
02/2023
1
COVID-19
01/2023
1
Aggressive Fibromatosis (Desmoid)
03/2022
Drug/Important Bio-Agent (IBA)
6
Estrogen Receptors
IBA
12/2023 - 08/2010
6
Biomarkers (Surrogate Marker)
IBA
11/2023 - 09/2008
6
Phosphotransferases (Kinase)
IBA
07/2023 - 11/2018
6
eribulin
FDA Link
01/2020 - 02/2015
5
Immune Checkpoint Inhibitors
IBA
12/2023 - 12/2021
5
human ERBB2 protein
IBA
12/2023 - 08/2010
5
taxane
IBA
11/2023 - 02/2015
4
Hormones (Hormone)
IBA
05/2024 - 10/2019
4
trastuzumab deruxtecan
IBA
05/2024 - 01/2021
4
Immunoconjugates (Immunoconjugate)
IBA
05/2024 - 11/2017
4
130-nm albumin-bound paclitaxel
IBA
12/2022 - 02/2021
4
Cisplatin (Platino)
FDA Link
Generic
10/2021 - 06/2008
4
Trastuzumab (Herceptin)
FDA Link
01/2021 - 01/2015
3
Circulating Tumor DNA
IBA
04/2024 - 09/2021
3
Alanine Transaminase (SGPT)
IBA
12/2023 - 08/2021
3
Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)
IBA
08/2023 - 03/2020
3
Antineoplastic Agents (Antineoplastics)
IBA
08/2023 - 01/2020
3
Paclitaxel (Taxol)
FDA Link
Generic
08/2021 - 10/2016
3
Gemcitabine
FDA Link
01/2020 - 12/2013
3
Anthracyclines
IBA
01/2020 - 02/2015
3
Tablets
IBA
10/2019 - 01/2019
2
abemaciclib
IBA
04/2024 - 01/2023
2
Tumor Biomarkers (Tumor Markers)
IBA
11/2023 - 06/2007
2
Tropomyosin
IBA
07/2023 - 03/2020
2
palbociclib
IBA
01/2023 - 06/2016
2
Cyclin-Dependent Kinase 4
IBA
01/2023 - 06/2016
2
DNA (Deoxyribonucleic Acid)
IBA
11/2022 - 06/2018
2
talazoparib
IBA
11/2022 - 12/2021
2
tyrosine receptor (receptor, tyrosine)
IBA
10/2022 - 11/2018
2
Ado-Trastuzumab Emtansine
IBA
02/2022 - 01/2021
2
Doxorubicin (Adriamycin)
FDA Link
Generic
12/2021 - 01/2020
2
Cyclophosphamide (Cytoxan)
FDA Link
Generic
12/2021 - 01/2020
2
Bevacizumab (Avastin)
FDA Link
08/2021 - 01/2020
2
Vinorelbine (Navelbine)
FDA Link
Generic
05/2021 - 06/2008
2
Lapatinib (GW572016)
FDA Link
01/2021 - 01/2015
2
Carboplatin (JM8)
FDA Link
Generic
01/2020 - 01/2020
2
olaparib
IBA
10/2019 - 01/2019
2
Monoclonal Antibodies
IBA
11/2017 - 09/2007
2
ErbB Receptors (EGF Receptor)
IBA
10/2016 - 06/2016
1
Arginase
IBA
04/2024
1
Epidermal Growth Factor (EGF)
IBA
04/2024
1
Formaldehyde (Formol)
FDA Link
01/2024
1
Paraffin
IBA
01/2024
1
Proteins (Proteins, Gene)
FDA Link
11/2023
1
Oxaliplatin (Eloxatin)
FDA Link
Generic
11/2023
1
mirogabalin
IBA
11/2023
1
futibatinib
IBA
02/2023
1
Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)
IBA
02/2023
1
Type 1 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 1)
IBA
02/2023
1
G-Protein-Coupled Receptors (Receptors, G Protein Coupled)
IBA
01/2023
1
Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)
IBA
11/2022
1
Enzyme Inhibitors (Inhibitors, Enzyme)
IBA
11/2022
1
larotrectinib
IBA
10/2022
1
entrectinib
IBA
10/2022
1
Insulin-Like Growth Factor II (Somatomedin A)
IBA
03/2022
1
Neutralizing Antibodies
IBA
03/2022
1
xentuzumab
IBA
03/2022
Therapy/Procedure
27
Therapeutics
05/2024 - 08/2010
21
Drug Therapy (Chemotherapy)
05/2024 - 06/2007
6
Genomic Medicine
12/2022 - 09/2018
4
Neoadjuvant Therapy
03/2021 - 12/2010
3
Immunotherapy
10/2023 - 03/2020
3
Adjuvant Chemotherapy
07/2022 - 12/2013
3
Precision Medicine
06/2021 - 06/2018
1
Intravenous Infusions
05/2024
1
Mastectomy (Mammectomy)
12/2023
1
Proton Therapy
12/2023